Zavabresib (OPN-2853)

Phase 1b/2a Study of PLX51107, a Small Molecule BET Inhibitor, in Subjects with Advanced Hematological Malignancies and Solid Tumors

• AUTHORS Patnaik, et al
• Programs Zavabresib (OPN-2853)

Download PDF